Young Un Choi | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Assist. Prof. Dr. Young Un Choi | Medicine and Dentistry | Best Researcher Award

Assistant Professor from WonJu Severance Christian Hospital, South Korea

Dr. Young Un Choi is a highly experienced Clinical Assistant Professor at Yonsei University Wonju College of Medicine, specializing in trauma surgery, emergency medicine, and critical care. Throughout his distinguished medical career, Dr. Choi has been committed to advancing trauma management and emergency surgical procedures through both clinical practice and academic research. He has accumulated extensive hands-on experience working in various hospitals, including service in international medical cooperation programs. His clinical expertise is complemented by his active engagement in numerous national and international trauma, surgery, and emergency care societies. Dr. Choi has published extensively in peer-reviewed journals, contributing significantly to the understanding of trauma mechanisms, surgical interventions, and critical care outcomes. His dedication to continuous learning is evident through his participation in globally recognized trauma certification courses and advanced surgical training programs. Dr. Choi’s research has had a positive impact on the development of trauma care protocols in South Korea, particularly in the establishment and improvement of regional trauma centers. His work addresses critical healthcare challenges, aiming to reduce mortality rates and improve the survival and recovery of severely injured patients. With a solid foundation in clinical excellence, academic rigor, and a vision for improving trauma systems, Dr. Choi stands out as a leading contributor in his field.

Professional Profile

Education

Dr. Young Un Choi has pursued a comprehensive medical education that forms the foundation of his clinical and research expertise. He began his medical studies at Inje University College of Medicine from March 2000 to February 2008, where he earned his medical degree. Demonstrating a strong interest in further specialization, he pursued a Master’s degree at the same institution from March 2011 to February 2017, focusing on advanced surgical practices and trauma management. His academic journey continued with a Ph.D. from Yonsei University Wonju College of Medicine, which he completed between March 2019 and February 2022. This doctoral program allowed him to delve deeply into the field of trauma surgery, focusing on the complex interrelationships between surgical techniques, patient outcomes, and trauma care systems. Throughout his academic development, Dr. Choi consistently balanced clinical responsibilities with advanced studies, equipping him with both theoretical knowledge and practical proficiency. His educational progression reflects a deliberate effort to strengthen his expertise in emergency medicine and critical care, positioning him to contribute meaningful advancements in these domains. The combination of medical, master’s, and doctoral degrees underscores his commitment to lifelong learning and clinical excellence, ultimately shaping him into a highly skilled and knowledgeable leader in trauma and critical care research.

Professional Experience

Dr. Young Un Choi has built an impressive career with extensive professional experience across multiple clinical and academic roles. He began his journey in 2008 as an intern doctor at Good Samsun Hospital, followed by residency training in surgery at Inje University Ilsan Paik Hospital from 2009 to 2013. His early focus on pediatric surgery led him to a short-term observer fellowship at Samsung Medical Center in 2013. From 2013 to 2015, he served as a clinical instructor in surgery at Inje University Ilsan Paik Hospital. His international exposure includes working as a medical doctor for the Korea International Cooperation Agency at the Korean-Laos Children’s Hospital between 2015 and 2016, contributing to global medical aid. In 2016, Dr. Choi joined Yonsei University as a Clinical Research Assistant Professor in trauma and intensive care, advancing through academic ranks to his current role as Clinical Associate Professor at Wonju Severance Christian Hospital. His career is marked by consistent growth in trauma surgery and critical care, and he has played a crucial role in clinical education and the development of trauma systems. His professional timeline showcases a dynamic balance between clinical excellence, academic service, and humanitarian medical missions.

Research Interest

Dr. Young Un Choi’s primary research interests focus on trauma surgery, emergency medicine, critical care management, and surgical outcomes in severely injured patients. His work consistently addresses challenges in managing complex trauma cases, particularly blunt abdominal and chest injuries, as well as the evaluation and optimization of diagnostic and surgical interventions. Dr. Choi is especially interested in improving the early identification of critical injuries, developing efficient trauma assessment methods, and refining surgical protocols to reduce mortality and complication rates. He has a strong focus on the utilization of radiographic techniques in trauma diagnosis, the prevention and management of surgical site infections, and strategies for enhancing survival in patients with severe polytrauma. Additionally, his research covers postoperative critical care and the role of advanced therapies such as immunoglobulin administration and antithrombin III in trauma patients. Dr. Choi also explores trauma care efficiency during mass gatherings and pandemics, as reflected in his study of trauma center responses during the COVID-19 outbreak. His body of research contributes to the global effort to improve trauma systems, optimize critical care practices, and develop evidence-based guidelines that can be applied both regionally and internationally.

Research Skills

Dr. Young Un Choi possesses a comprehensive skill set in trauma surgery, emergency procedures, critical care, and clinical research methodologies. He is proficient in advanced trauma life support (ATLS), emergency surgical techniques, preperitoneal pelvic packing, and hemodynamic stabilization strategies for severely injured patients. Dr. Choi is highly skilled in utilizing diagnostic tools such as chest radiography and computed tomography in emergency trauma settings, allowing for rapid and accurate injury assessment. His clinical expertise extends to the management of complex abdominal and thoracic injuries, as well as the application of advanced resuscitation protocols in critical care. In addition to his clinical abilities, Dr. Choi is adept at conducting retrospective and prospective clinical studies, employing data analysis, outcome measurement, and cohort study designs to derive meaningful conclusions from patient cases. His proficiency in multi-disciplinary trauma care and his ability to integrate research into clinical practice are evident throughout his published work. Furthermore, he has strong teaching and mentorship skills, regularly contributing to academic activities, surgical training, and national trauma courses. Dr. Choi’s unique combination of hands-on surgical skills, trauma management expertise, and rigorous clinical research make him a valuable contributor to both academic and hospital settings.

Awards and Honors

Dr. Young Un Choi’s distinguished career is supported by several certifications, memberships, and recognitions in the field of trauma and emergency medicine. He holds board certifications in general surgery, trauma surgery, critical care medicine, and emergency trauma surgery, reflecting his multi-specialty proficiency. Dr. Choi has completed numerous internationally recognized training programs, including Advanced Trauma Life Support (ATLS) from Sunnybrook Health Sciences Centre in Canada and the Definitive Surgical Trauma Care (DSTC) course in Sydney, Australia. He is certified in specialized courses such as Advanced Trauma Operative Management (ATOM) and Korean Advanced Life Support (KALS), among others. Dr. Choi is an active member of several professional societies, including the Korean Surgical Society, the Korean Society of Acute Care Surgery, the Korean Society of Traumatology, and the Korean Society of Critical Care Medicine. His involvement in these organizations signifies his dedication to continuous professional development and knowledge dissemination. In addition to his certifications and society memberships, Dr. Choi has served as an instructor for several national trauma training courses, playing a vital role in the education and training of upcoming trauma surgeons and emergency care providers. His honors and certifications underscore his expertise and leadership in the trauma field.

Conclusion

Dr. Young Un Choi is a dedicated and highly skilled trauma surgeon and clinical researcher whose contributions to emergency and critical care medicine are both extensive and impactful. His academic journey, clinical excellence, and substantial research output position him as a leader in trauma care in South Korea. Through his focused research on trauma mechanisms, surgical interventions, and critical care strategies, Dr. Choi has significantly advanced the understanding and management of severe trauma cases. His consistent participation in national and international trauma societies and his role in surgical education further highlight his influence within the medical community. Although his accomplishments are already remarkable, Dr. Choi has opportunities to expand his global collaborations, increase involvement in multicenter trials, and explore innovative technologies to further elevate his contributions to the field. His ability to balance clinical duties, research, and education is commendable and demonstrates his commitment to improving patient care and trauma system efficiency. Overall, Dr. Choi’s professional journey reflects a rare combination of surgical expertise, academic dedication, and passion for advancing trauma care, making him a deserving candidate for the Best Researcher Award.

Publications Top Notes

  • Differences in Characteristics of Trauma Between General Trauma and Suicidal Trauma–Trauma Mechanism, Injury Site, and Severity: A Single‐Center Study
    Ji Young Hyun, Yae Jun Son, SuHyun Kim, Keum Seok Bae, Jae Sik Chung, Il Hwan Park, Young Un Choi, Roberto Cirocchi
    2025

  • Mortality Trends in Chest-Abdominal Trauma Patients Before and After the Establishment of Trauma Centers in South Korea
    Dae Ryong Kang, Hye Sim Kim, Ji Young Jang, Ou-Hyen Kim, Kiyoung Kim, Un Young Choi, Jiwool Ko, Keum Seok Bae, Hongjin Shim
    2024

  • Occult Pneumothorax in Patients with Blunt Chest Trauma: Key Findings on Supine Chest Radiography
    Il Hwan Park, Chang Wan Kim, Young Un Choi, Tae Wook Kang, Jihye Lim, Chun Sung Byun
    2023

  • Association of Chest Anteroposterior Radiography with Computed Tomography in Patients with Blunt Chest Trauma
    Young Un Choi, Chang Whan Kim, JiHye Lim, Il Hwan Park, Chun Sung Byun, Roberto Cirocchi
    2023

  • Effect of Antithrombin III Administration on the Prognosis of Severe Trauma Patients with Disseminated Intravascular Coagulation
    Jae Sik Chung, Myoung Jun Kim, Young Un Choi, Jun Gi Kim, Keum Seok Bae
    2023

  • Adjuvant Intravenous Immunoglobulin Administration on Postoperative Critically Ill Patients with Secondary Peritonitis: A Retrospective Study
    Young Un Choi, Jun Gi Kim, Ji Young Jang, Tae Hwa Go, Kwangmin Kim, Keum Seok Bae, Hongjin Shim
    2023

  • Outcomes Improvement Despite Continuous Visits of Severely Injured Patients During the COVID-19 Outbreak: Experience at a Regional Trauma Centre in South Korea
    Young Un Choi
    2022

  • Determination of Risk Factors for Predicting Bladder-Urethra Injury in Cases of Pelvic Bone Fracture: A Retrospective Single Center Study
    Ji Wool Ko, Myoung Jun Kim, Young Un Choi, Hongjin Shim, Hoejeong Chung, Ji Young Jang, Keum Seok Bae, Kwangmin Kim
    2022

  • A Study on Trauma Mechanisms and Injury Sites in Patients with Blunt Abdominal Trauma
    YoungUn Choi, SuHyun Kim, JiWool Ko, MyoungJun Kim, Hongjin Shim, JaeHun Han, JiHye Lim, Kwangmin Kim, Roberto Cirocchi
    2022

  • Determination of Risk Factors Associated with Surgical Site Infection in Patients Undergoing Preperitoneal Pelvic Packing for Unstable Pelvic Fracture
    Kang Min Kim, Myoung Jun Kim, Jae Sik Chung, Ji Wool Ko, Young Un Choi, Hongjin Shim, Ji Young Jang, Keum Seok Bae, Kwangmin Kim
    2022

Guoguo Jin | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Assoc. Prof. Dr. Guoguo Jin | Medicine and Dentistry | Best Researcher Award

Deputy Director from Key Laboratory of Chronic Disease Health Management of Henan Province, China

Dr. Guoguo Jin is an accomplished biomedical researcher specializing in the chemical prevention of tumors. With a strong foundation in pathology and bioengineering, she has steadily developed a research career that bridges cancer biology and cardiovascular complications arising from oncological treatments. Her work delves into the molecular mechanisms underlying tumorigenesis, cardiotoxicity from chemotherapeutic agents, and the identification of therapeutic targets for various cancers, particularly esophageal, gastric, and colon carcinomas. Dr. Jin currently serves as the Deputy Director of both the Key Laboratory of Chronic Disease Health Management and the Department of Scientific Research and Discipline Construction at Fuwai Central China Cardiovascular Hospital. She has led several national and provincial-level research projects and has published extensively in top-tier journals. Her research contributions are complemented by multiple patents aimed at mitigating drug-induced cardiotoxicity. Recognized for her leadership and scientific acumen, she has received accolades such as the Young and Middle-aged Academic Leader title from the Health Commission of Henan Province. Overall, Dr. Jin’s work represents a compelling blend of scientific rigor, clinical relevance, and translational potential. Her continued efforts are likely to yield significant advancements in cancer therapy and patient care.

Professional Profile

Education

Dr. Guoguo Jin began her academic journey in bioengineering, earning her Master’s degree from the School of Bioengineering at Zhengzhou University in July 2011. This foundational training equipped her with critical insights into biomedical sciences and experimental techniques. She then pursued her doctoral studies in pathology and pathophysiology at the Basic Medical College of Zhengzhou University, receiving her Ph.D. in July 2017. During her doctoral program, she was selected for an international joint training opportunity and spent two years (2015–2017) at the prestigious Hormel Institute, University of Minnesota. There, she conducted in-depth research into the signal transduction pathways related to tumorigenesis and its prevention. Her time abroad not only enriched her technical competencies but also exposed her to cutting-edge methodologies in cancer biology. This combination of local and international academic training has laid a solid foundation for her ongoing research into tumor mechanisms and therapeutic strategies. Dr. Jin’s educational background reflects a trajectory of consistent academic excellence and scientific curiosity, establishing her as a capable and knowledgeable researcher in the fields of oncology and pathology.

Professional Experience

Dr. Guoguo Jin currently holds dual leadership roles at Fuwai Central China Cardiovascular Hospital, where she serves as Deputy Director of both the Key Laboratory of Chronic Disease Health Management of Henan Province and the Department of Scientific Research and Discipline Construction. Her professional responsibilities primarily involve overseeing tumor-related research and institutional academic development. Earlier in her career, she gained international experience at the Hormel Institute, University of Minnesota, where she focused on cancer signal transduction pathways. This exposure to high-impact research environments significantly influenced her approach to scientific inquiry. Throughout her career, Dr. Jin has successfully led multiple research projects funded at both national and provincial levels. These projects explore the molecular mechanisms of drug-induced cardiotoxicity, tumor progression, and the discovery of small-molecule inhibitors. Her clinical and translational research activities are closely integrated with her hospital’s goals, enhancing the relevance and impact of her findings. With a strong blend of laboratory management, project leadership, and interdepartmental coordination, Dr. Jin’s professional journey reflects her growth from a bench scientist to an influential figure in medical research administration. Her dual roles in scientific research and academic governance enable her to contribute meaningfully to both science and institutional progress.

Research Interest

Dr. Guoguo Jin’s primary research interest lies in the chemical prevention of tumors, with a focus on uncovering the molecular mechanisms that drive carcinogenesis and treatment-related complications. She is particularly interested in the pathways that regulate tumor initiation and progression in gastrointestinal cancers such as esophageal, gastric, and colon cancer. A significant portion of her work also explores the cardiotoxic effects of chemotherapeutic agents like osimertinib and doxorubicin, aiming to develop strategies to mitigate these adverse outcomes. Her recent studies have investigated the roles of signaling molecules such as WNK1, hnRNPU, AHCY-LDHA, and ZIP8 in cancer development and progression. Dr. Jin is also deeply involved in the identification and evaluation of small-molecule inhibitors and natural compounds like α-mangostin and curcumin for their anti-tumor efficacy. Her research bridges basic science and clinical application, positioning her work at the forefront of translational oncology. Through the development of targeted therapies and predictive biomarkers, she aims to improve both treatment outcomes and quality of life for cancer patients. This integrated focus on cancer biology and cardiotoxicity underlines her commitment to advancing personalized medicine in oncology.

Research Skills

Dr. Guoguo Jin possesses a wide array of research skills, especially in molecular and cellular biology techniques relevant to oncology. She is proficient in signal transduction analysis, gene expression profiling, histone modification studies, and functional validation of oncogenes and tumor suppressors. Her expertise extends to the use of in vitro and in vivo cancer models to study the efficacy and mechanisms of chemopreventive agents. She has demonstrated a high level of competence in utilizing molecular techniques such as Western blotting, qRT-PCR, immunohistochemistry, and chromatin immunoprecipitation assays. Her postdoctoral training at the Hormel Institute allowed her to master advanced techniques for dissecting signaling pathways in cancer. In addition to experimental skills, Dr. Jin has a solid foundation in project design, grant writing, and data analysis. She is also skilled in translating laboratory findings into potential therapeutic applications, as demonstrated by her patents. Moreover, her ability to manage multidisciplinary teams and coordinate with clinical departments enhances the practical relevance of her research. These competencies enable her to effectively lead complex biomedical projects from conceptualization to execution and dissemination.

Awards and Honors

Dr. Guoguo Jin has received multiple awards and honors that underscore her impact and promise in the field of medical research. In February 2024, she was selected as a Young and Middle-aged Academic Leader in Health and Wellness by the Health Commission of Henan Province, a recognition of her leadership in translational cancer research. Later that year, she was awarded a position in the National-Level Talent Cultivation Project for First-Class Discipline in Clinical Medicine at Zhengzhou University. Dr. Jin has also secured several competitive research grants, including the National Natural Science Foundation Youth Project, the Science and Technology Tackling Project by the Department of Science and Technology of Henan Province, and the Outstanding Young Talent Training Program for Health and Technology Innovation. Her innovative research on cancer prevention and cardiotoxicity has led to two patents, further highlighting her commitment to developing clinically relevant solutions. These accolades reflect not only her scientific excellence but also her dedication to advancing health outcomes through rigorous and applied research. The consistent support from national and provincial agencies illustrates her status as a leading figure in her domain.

Conclusion

Dr. Guoguo Jin exemplifies the qualities of a leading researcher with her focused expertise in chemical tumor prevention and translational oncology. Her well-rounded background—from robust academic training to leadership in high-impact research—positions her as a valuable contributor to both the scientific community and clinical practice. Her studies on molecular mechanisms of cancer progression and cardiotoxicity have not only expanded academic understanding but have also offered practical pathways for improving patient outcomes. Through national and provincial grants, influential publications, and patented innovations, she continues to push the boundaries of cancer therapy and prevention. While her research is already making a meaningful impact, future expansion into international collaborations and clinical trials could further elevate her contributions. Overall, Dr. Jin’s career is marked by scientific rigor, visionary leadership, and a commitment to translating research into real-world solutions. She is a highly deserving candidate for recognition through honors such as the Best Researcher Award and is likely to make even greater strides in cancer research in the years to come.

Publications Top Notes

  1. Title: STIP1 drives metabolic reprogramming in esophageal squamous cell carcinoma via AHCY-LDHA axis
    Authors: Jin G, Song Y, Yan M, Fang S, Shao Y, Zhao K, Liu M, Guo Q, Jia X, Zhang C, Wang Z, Liu K, Li X, Zhao S, Guo Z, Dong Z
    Year: 2025

  2. Title: hnRNPU-mediated pathogenic alternative splicing drives gastric cancer progression
    Authors: Jin G, Song Y, Fang S, Yan M, Yang Z, Shao Y, Zhao K, Liu M, Wang Z, Guo Z, Dong Z
    Year: 2025

  3. Title: ZIP8 modulates ferroptosis to drive esophageal carcinoma progression
    Authors: Yang Z, Zhao K, Li X, Yanzhang R, Zhang H, Yu Y, Yan M, Fang S, Li T, Li H, Chu X, Han S, Zhang Z, Teng J, Jin G, Guo Z
    Year: 2025

  4. Title: Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancer
    Authors: Jin G, Yan M, Liu K, Yao K, Chen H, Zhang C, Yi Y, Reddy K, Gorja DR, Laster KV, Guo Z, Dong Z
    Year: 2020

  5. Title: Ginger extract inhibits c-MET activation and suppresses osteosarcoma in vitro and in vivo
    Authors: Yanzhang R, Yan M, Yang Z, Zhang H, Yu Y, Li X, Shen R, Chu X, Han S, Zhang Z, Teng J, Li H, Li T, Jin G, Guo Z
    Year: 2025

  6. Title: PDK1-mediated phosphorylation of USP5 modulates NF-κB signalling to enhance osteosarcoma growth
    Authors: Yang Z, Yu Z, Teng J, Yanzhang R, Yu Y, Zhang H, Jin G, Wang F
    Year: 2025

  7. Title: Precision therapy for cancer prevention by targeting carcinogenesis
    Authors: Jin G, Liu K, Guo Z, Dong Z*
    Year: 2024

  8. Title: Decrypting the Molecular Mechanistic Pathways Delineating the Chemotherapeutic Potential of Ruthenium-Phloretin Complex in Colon Carcinoma Correlated with the Oxidative Status and Increased Apoptotic Events
    Authors: Jin G, Zhao Z, Chakraborty T, et al.
    Year: 2020

  9. Title: Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma
    Authors: Zhao Z, Jin G, Yao K, Liu K, Liu F, Chen H, Wang K, Gorja DR, Reddy K, Bode A.M., Guo Z, Dong Z
    Year: 2019

  10. Title: Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway
    Authors: Li D, Wang G, Jin G, Yao K, Zhao Z, Bie L, Guo Y, Li N, Deng W, Chen X, Chen B, Liu Y, Luo S, Guo Z
    Year: 2019

Kumiko Tajima | Medicine and Dentistry | Women Researcher Award

Posted on by Shen Awards

Dr. Kumiko Tajima | Medicine and Dentistry | Women Researcher Award

Manager from Gunma Central Hospital, Japan

Kumiko Tajima is a highly qualified medical professional with extensive experience in internal medicine and diabetes care. She graduated from Gunma University School of Medicine in 1992 and completed graduate studies at Gunma University Graduate School in 1999. With over two decades of clinical practice, she has served at several prominent medical institutions in Japan, including Gunma University School of Medicine, National Takasaki Hospital, and Gunma Prefectural Cardiovascular Center. Since 2014, she has been practicing at Gunma Central Hospital. Kumiko is recognized as a certified physician by the Japanese Society of Internal Medicine and specializes in general internal medicine and diabetes management. Her career is marked by a strong commitment to patient care, education, and specialized training, including roles as an instructor for medical training programs. She also serves vulnerable populations as a designated physician for disabilities and intractable diseases. While her clinical expertise is well documented, her research involvement is not explicitly detailed in the information available, suggesting a potential focus on clinical practice and medical education over research output. Nevertheless, her professional credentials and dedication to healthcare highlight her as a respected figure in the medical community.

Professional Profile

Education

Kumiko Tajima completed her formal education at Gunma University, one of Japan’s reputable institutions. She graduated from the Gunma University School of Medicine in 1992, where she acquired the foundational knowledge and clinical skills required to pursue a medical career. Following her medical degree, she advanced her expertise by completing graduate studies at Gunma University Graduate School in 1999. This postgraduate education likely included clinical research or advanced medical training, equipping her with enhanced knowledge in medical sciences. Her educational background provided a strong base for her subsequent clinical work and certifications in various medical specialties. Being an alumna of the same university for both undergraduate and graduate studies suggests continuity and depth in her academic preparation. Her education set the stage for her later roles in internal medicine, diabetes specialization, and her involvement in training programs. The rigorous training at Gunma University, known for its emphasis on both research and clinical practice, has likely influenced her professional trajectory, balancing patient care with medical education.

Professional Experience

Kumiko Tajima has accumulated significant clinical experience working in multiple prestigious medical institutions across Japan. Early in her career, she worked at Gunma University School of Medicine, which provided her with exposure to academic medicine and clinical research environments. She also served at National Takasaki Hospital, Tatebayashi Kosei Hospital, and Gunma Prefectural Cardiovascular Center, gaining diverse experience in patient care across various specialties and healthcare settings. Since 2014, she has been a key medical professional at Gunma Central Hospital, where she continues to provide specialized care in internal medicine and diabetes management. Throughout her career, she has been recognized for her expertise by multiple Japanese medical societies, reflected in her qualifications as a certified physician and specialist. She holds important roles such as a training instructor for diabetes care and general medical training, indicating her leadership in mentoring younger physicians. Additionally, her designation as a physician under the Welfare Act for the Physically Disabled and for intractable diseases highlights her involvement in public health and complex patient populations. Her extensive clinical roles demonstrate a strong foundation in both patient care and medical education.

Research Interests

While explicit details about Kumiko Tajima’s research interests are not provided in the information available, it is reasonable to infer that her research focus aligns closely with her clinical specialties—internal medicine and diabetes. Given her certifications and instructor roles within the Japan Diabetes Society, she likely engages with research related to diabetes management, treatment outcomes, and possibly public health aspects of chronic diseases. Her designation as a physician responsible for intractable diseases suggests potential interest in complex, difficult-to-treat conditions that may require innovative clinical approaches or translational research. Moreover, her role in general medical training indicates a probable interest in medical education research or clinical practice improvement. Without specific publications or ongoing research projects mentioned, her primary contributions may be in applying clinical knowledge to patient care and educating the next generation of physicians. If involved in research, it may focus on improving clinical protocols, diabetes education, or interdisciplinary care for chronic disease patients. Confirmation of such interests would strengthen her profile as a clinician-researcher.

Research Skills

Kumiko Tajima’s documented expertise suggests strong clinical skills particularly in internal medicine, diabetes care, and training future medical professionals. As a certified specialist and instructor in diabetes, she likely possesses advanced skills in managing complex cases, interpreting clinical data, and applying evidence-based medicine. Her role as an industrial physician and designated physician for the disabled reflects proficiency in occupational health and specialized patient management. Although there is no explicit mention of laboratory or bench research skills, her graduate education and clinical roles imply familiarity with clinical research methodologies, patient data analysis, and possibly clinical trial participation. Her instructional roles also suggest capabilities in curriculum development, clinical supervision, and medical education, which are important research-adjacent skills. If involved in research activities, these skills would be foundational for clinical studies, epidemiological research, or healthcare quality improvement projects. To enhance her research profile, further skills in scientific writing, grant applications, and collaboration in research networks would be beneficial.

Awards and Honors

The provided information does not list any specific awards or honors received by Kumiko Tajima. However, her qualifications as a certified physician by reputable Japanese medical societies, and her appointment as a specially appointed instructor for general medical training, indicate professional recognition within the medical community. These certifications and instructor roles can be seen as professional honors reflecting her expertise and dedication to clinical excellence and education. Additionally, her designation as a physician for intractable diseases and disabilities suggests recognition of her specialized skills and trust placed in her by public health authorities. While no formal awards are cited, her career achievements and appointments demonstrate a high level of respect and acknowledgment from her peers and regulatory bodies. Should she have received awards related to clinical innovation, research contributions, or teaching excellence, including these would enhance her profile for awards specifically focused on research.

Conclusion

Kumiko Tajima is an experienced and highly qualified medical professional with strong credentials in internal medicine and diabetes care. Her clinical expertise, long-standing service in multiple hospitals, and roles in medical training and specialized care demonstrate her dedication to both patient health and medical education. While she holds numerous certifications and leadership roles within professional medical societies, her profile lacks explicit information on research outputs, publications, or scientific contributions. For a Women Researcher Award focused on research excellence, evidence of active research involvement or scholarly achievements would be necessary to strengthen her candidacy. Nevertheless, her commitment to specialized clinical care, training, and vulnerable patient populations underscores her valuable role in the healthcare system. If supplemented by further details on her research activities, Kumiko Tajima could be a strong candidate. Currently, her profile is more aligned with clinical leadership and education, rather than research-centric recognition.

Publications Top Notes

  1. A case of SHORT syndrome with a novel genetic mutation diagnosed 19 years after the onset of diabetes

    • Authors: Kumiko Tajima, Yushi Hirota, Tomofumi Takayoshi, Wataru Ogawa

    • Year: 2025

  2. Medical Mystery: Abnormal Abdominal Radiograph — The Answer

    • Authors: Masahiko Kurabayashi, Kumiko Tajima

    • Year: 2007

  3. Medical Mystery — Abnormal Abdominal Radiograph

    • Authors: Kumiko Tajima, Masahiko Kurabayashi

    • Year: 2006

Guanbo Wang | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Dr. Guanbo Wang | Medicine and Dentistry | Best Researcher Award

Assistant Professor from The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, United States

Dr. Guanbo Wang is a distinguished postdoctoral research fellow at the CAUSALab, Harvard T.H. Chan School of Public Health. With a robust background in biostatistics and epidemiology, his work primarily focuses on developing innovative statistical methodologies to enhance causal inference in public health research. Dr. Wang’s expertise lies in integrating complex data sources to derive meaningful insights into treatment effects, particularly in the context of randomized clinical trials and observational studies. His interdisciplinary approach combines rigorous statistical theory with practical applications, aiming to inform clinical decision-making and health policy. Throughout his academic and professional journey, Dr. Wang has demonstrated a commitment to advancing public health through methodological innovation and collaborative research.

Professional Profile

Education

Dr. Wang’s academic journey commenced with a Bachelor of Science degree from China Textile University in Shanghai, China, in 1999. He pursued further studies at Shanghai Jiao Tong University, earning a Master of Science in 2002 and a Ph.D. in 2005. His doctoral research laid the foundation for his future endeavors in biostatistics and epidemiology. In 2019, Dr. Wang expanded his academic horizons as a visiting scholar at Harvard University, engaging with leading experts in the field. He culminated his formal education with a Ph.D. in Biostatistics from McGill University in 2022, where he honed his skills in statistical modeling and causal inference. Dr. Wang’s comprehensive educational background equips him with the theoretical knowledge and practical expertise necessary for his contributions to public health research.

Professional Experience

Dr. Wang’s professional experience encompasses a blend of academic research and industry collaboration. From 2015 to 2022, he served as a research assistant at McGill University and the McGill University Health Centre Research Institute, contributing to various projects in biostatistics and epidemiology. His industry experience includes internships and consultancy roles at prominent organizations such as Biogen, Roche, Baker & McKenzie, FINEOS Co., Ltd., KPMG China, and AXA Insurance Group. These roles provided Dr. Wang with practical insights into the application of statistical methods in diverse settings, including pharmaceuticals, legal consulting, and insurance. In 2023, he collaborated with the Center for Biostatistics in AIDS Research (CBAR), further solidifying his expertise in clinical trial analysis. Dr. Wang’s multifaceted professional background reflects his adaptability and commitment to applying statistical methodologies to real-world challenges.

Research Interests

Dr. Wang’s research interests are centered on advancing causal inference methodologies to address complex questions in public health. He focuses on data integration techniques that allow for the extension of causal inferences across different populations and data sources. His work on treatment effect heterogeneity aims to identify subpopulations that may benefit differently from interventions, thereby informing personalized medicine approaches. Dr. Wang also explores innovative trial designs, including adaptive and Bayesian frameworks, to enhance the efficiency and ethical conduct of clinical studies. Additionally, he is interested in incorporating prior knowledge, such as expert opinions, into statistical models to improve their interpretability and relevance. His methodological contributions are applied across various disease areas, including cardiovascular diseases, cancer, infectious diseases, and mental health disorders.

Research Skills

Dr. Wang possesses a comprehensive skill set in statistical methodologies and data analysis. His expertise includes nonparametric and semiparametric statistics, machine learning, high-dimensional data analysis, survival analysis, and optimization techniques. He is proficient in handling complex data structures, such as time-dependent treatments and longitudinal outcomes, commonly encountered in clinical and observational studies. Dr. Wang is adept at utilizing programming languages like R, Python, and C++ for statistical computing and developing analytical tools. His experience spans various data sources, including randomized clinical trials, electronic health records, and administrative databases. This diverse skill set enables him to tackle intricate research questions and contribute to methodological advancements in public health.

Awards and Honors

Dr. Wang’s contributions to biostatistics and public health research have been recognized through numerous awards and honors. He received the Fonds de Recherche du Québec – Santé Doctoral Training Grant (2019-2022), acknowledging his potential in health research. In 2021, he was honored with the Centre de Recherches Mathématiques StatLab Graduate Award and the McGill GREAT Award, reflecting his academic excellence. His achievements also include the McGill Graduate Excellence Award (2016-2021), the McGill Mobility Award (2019), and the McGill University Health Centre Studentship Fellowship (2019). Additionally, he was awarded the Statistical Society of Canada Biostatistics Travel Award in 2018. These accolades underscore Dr. Wang’s dedication to advancing statistical methodologies and their application in public health.

Conclusion

Dr. Guanbo Wang exemplifies a commitment to enhancing public health through methodological innovation in biostatistics and epidemiology. His extensive education and diverse professional experiences have equipped him with a robust foundation to address complex health research questions. Dr. Wang’s research endeavors aim to refine causal inference techniques, improve clinical trial designs, and integrate diverse data sources for comprehensive analyses. His contributions have the potential to inform evidence-based decision-making and personalized healthcare strategies. As he continues his work at the CAUSALab, Dr. Wang remains at the forefront of developing statistical methodologies that bridge the gap between data and impactful public health interventions.

Publications Top Notes

  1. Causal inference with multiple concurrent medications: A comparison of methods and an application in multidrug-resistant tuberculosis
    Authors: A.A. Siddique, M.E. Schnitzer, A. Bahamyirou, G. Wang, T.H. Holtz, G.B. Migliori, et al.
    Journal: Statistical Methods in Medical Research, 28(12), 3534–3549
    Year: 2019
    Citations: 31

  1. Estimating treatment importance in multidrug-resistant tuberculosis using Targeted Learning: An observational individual patient data network meta-analysis
    Authors: G. Wang, M.E. Schnitzer, D. Menzies, P. Viiklepp, T.H. Holtz, A. Benedetti
    Journal: Biometrics, 76(3), 1007–1016
    Year: 2020
    Citations: 17

  2. Using Effect Scores to Characterize Heterogeneity of Treatment Effects
    Authors: G. Wang, P.J. Heagerty, I.J. Dahabreh
    Journal: Journal of the American Medical Association
    Year: 2024
    Citations: 16

  1. Modeling treatment effect modification in multidrug-resistant tuberculosis in an individual patient data meta-analysis
    Authors: Y. Liu, M.E. Schnitzer, G. Wang, E. Kennedy, P. Viiklepp, M.H. Vargas, et al.
    Journal: Statistical Methods in Medical Research, 31(4), 689–705
    Year: 2022
    Citations: 10

  2. Evaluating hybrid controls methodology in early-phase oncology trials: A simulation study based on the MORPHEUS-UC trial
    Authors: G. Wang, M.P. Costello, H. Pang, J. Zhu, H.J. Helms, I. Reyes-Rivera, R.W. Platt, et al.
    Journal: Pharmaceutical Statistics, 23(1), 31–45
    Year: 2023
    Citations: 8

  3. Predictive factors of detectable viral load in HIV-infected patients
    Authors: A. Bouchard, F. Bourdeau, J. Roger, V.T. Taillefer, N.L. Sheehan, M. Schnitzer, G. Wang, et al.
    Journal: AIDS Research and Human Retroviruses, 38(7), 552–560
    Year: 2022
    Citations: 8

  4. Penalized G-estimation for effect modifier selection in the structural nested mean models for repeated outcomes
    Authors: A. Jaman, G. Wang, A. Ertefaie, M. Bally, R. Lévesque, R. Platt, M. Schnitzer
    Journal: Biometrics, 81(1)
    Year: 2024
    Citations: 5

  5. Robust integration of external control data in randomized trials
    Authors: G. Wang, R. Karlsson, J.H. Krijthe, I.J. Dahabreh
    Journal: arXiv preprint, arXiv:2406.17971
    Year: 2024
    Citations: 4

  1. Association between Sitting Time and Urinary Incontinence in the US Population: Data from the National Health and Nutrition Examination Survey (NHANES) 2007 to 2018
    Authors: D. Xingpeng, Y. Chi, X. Liyuan, W. Guanbo, L. Banghua
    Journal: Heliyon, 10(6)
    Year: 2024
    Citations: 4

  1. Integrating complex selection rules into the latent overlapping group Lasso for constructing coherent prediction models
    Authors: G. Wang, S. Perreault, R.W. Platt, R. Wang, M. Dorais, M.E. Schnitzer
    Journal: Statistics in Medicine
    Year: 2025
    Citations: 3

 

EBUBEKİR KAPLAN | Health Professions | Best Researcher Award

Posted on by Shen Awards

Assist. Prof. Dr. EBUBEKİR KAPLAN | Health Professions | Best Researcher Award

Assist. Prof. Dr. from Van Yüzüncü Yıl University, Turkey

Dr. Ebubekir Kaplan is a distinguished Turkish neurosurgeon renowned for his expertise in spinal surgery and neuroanatomy. With a career spanning over two decades, he has made significant contributions to both clinical practice and academic research. Dr. Kaplan has held various leadership roles in national and international neurosurgical societies, reflecting his commitment to advancing the field. His research interests encompass spinal deformities, degenerative spinal disorders, and the development of innovative surgical techniques. He has been recognized with numerous awards for his scientific contributions and has actively participated in the development of clinical guidelines and educational programs. Dr. Kaplan’s dedication to excellence in neurosurgery and his continuous pursuit of knowledge have solidified his reputation as a leading figure in the medical community.

Professional Profile

Education

Dr. Kaplan’s educational journey began with a medical degree from Trakya University Faculty of Medicine. He further specialized in neurosurgery, completing his residency and gaining substantial clinical experience. Demonstrating a strong interest in research, Dr. Kaplan pursued a Ph.D. in Anatomy, focusing on spinal structures and their clinical implications. His commitment to continuous learning led him to participate in various international training programs, including cadaver courses at the Cleveland Clinic and fellowships in spinal deformity surgery. These educational experiences have equipped Dr. Kaplan with a comprehensive understanding of both the theoretical and practical aspects of neurosurgery, enabling him to contribute significantly to the field through research, teaching, and clinical practice.

Professional Experience

Dr. Kaplan’s professional career is marked by a blend of clinical excellence and academic involvement. He has served as a faculty member at Trakya University, where he has been instrumental in training the next generation of neurosurgeons. Clinically, Dr. Kaplan has focused on spinal surgery, addressing complex cases involving degenerative disorders and spinal deformities. His expertise has been recognized through appointments to various committees, including the North American Spine Society’s International Education Committee and the AOSpine European Research Council. Dr. Kaplan’s involvement in these organizations underscores his commitment to advancing neurosurgical practices and education on a global scale. His professional journey reflects a dedication to improving patient outcomes through both hands-on surgical interventions and the dissemination of knowledge.

Research Interests

Dr. Kaplan’s research interests are deeply rooted in spinal surgery and neuroanatomy. He has extensively studied cervical and lumbar degenerative spinal disorders, aiming to enhance surgical techniques and patient care. His work on spinal deformities has contributed to the development of innovative surgical approaches and instrumentation. Dr. Kaplan is also interested in the anatomical variations of the spine and their clinical significance, which has implications for both diagnosis and surgical planning. His research often bridges the gap between clinical practice and anatomical science, providing valuable insights that inform surgical strategies. Dr. Kaplan’s commitment to research is evident in his numerous publications and presentations at national and international conferences.

Research Skills

Dr. Kaplan possesses a robust set of research skills that encompass both clinical and anatomical studies. His proficiency in conducting cadaveric dissections has allowed him to explore spinal anatomy in depth, leading to a better understanding of surgical landmarks and potential complications. He is adept at designing and implementing clinical studies, analyzing outcomes to improve surgical techniques and patient care. Dr. Kaplan’s collaborative approach has led to multidisciplinary research projects, integrating perspectives from various medical specialties. His ability to translate complex anatomical findings into practical surgical applications demonstrates his skill in bridging basic science and clinical practice. Dr. Kaplan’s research acumen is further evidenced by his contributions to peer-reviewed journals and his role in developing clinical guidelines.

Awards and Honors

Dr. Kaplan’s contributions to neurosurgery have been recognized through numerous awards and honors. He received the second place at the Society for Experimental Mechanics 2004 Student Paper Competition and honorable mention at the Turkish Neurosurgical Society 2006 Scientific Congress. In 2007, he won the best spinal paper award at the Turkish Neurosurgical Society Scientific Congress and received the AOSpine/European Association of Neurosurgical Societies’ Fellowship. His innovative work on the Interlocked Double Sacrum Screw System earned him the Spine Technology Award in 2013 and the Turkish Neurosurgical Society Patent Award in 2014. Dr. Kaplan has also been honored with the Trakya University Scientific Publication Performance Award and the Ankara Güven Hospital Award for the best surgical paper. These accolades reflect his dedication to advancing neurosurgical techniques and improving patient outcomes.

Conclusion

Dr. Ebubekir Kaplan’s career exemplifies a harmonious blend of clinical expertise, academic scholarship, and innovative research. His extensive work in spinal surgery and neuroanatomy has not only advanced surgical practices but also enriched the academic community through education and guideline development. Dr. Kaplan’s commitment to excellence is evident in his numerous awards and leadership roles within professional societies. His research has led to significant advancements in understanding spinal disorders and developing surgical techniques, ultimately enhancing patient care. As a mentor, educator, and researcher, Dr. Kaplan continues to inspire and contribute to the field of neurosurgery, leaving a lasting impact on both his peers and the patients he serves.

Publications Top Notes

  1. Title: The effect of nursing care based on Comfort Theory of Kolcaba on comfort, satisfaction and sleep quality of intensive care patients
    Journal: Nursing in Critical Care
    Year: 2025
    DOI: 10.1111/nicc.70033
    Contributors: Ebubekir Kaplan, Aylin Özakgül

  2. Title: Investigation of the relationship between spiritual care needs of relatives of patients hospitalized in intensive care unit and intensive care satisfaction in Turkey
    Journal: Nursing in Critical Care
    Year: 2024
    DOI: 10.1111/nicc.13024
    EID: 2-s2.0-85182721942
    Contributors: Ebubekir Kaplan, Özkan Sir, Aylin Özakgül

  3. Title: The Effect of Cold Spray Applied Before Local Anesthesia on Anxiety and Pain in Coronary Angiography Procedure: A Randomized Controlled Study
    Journal: Journal of Perianesthesia Nursing
    Year: 2024
    DOI: 10.1016/j.jopan.2024.09.001
    EID: 2-s2.0-85212649889
    Contributors: Özkan Sir, Ebubekir Kaplan, Tuğba Akbulut

  4. Title: Yoğun Bakım Hastası İçin Erken Mobilizasyonun Önemi
    Journal: Sakarya Üniversitesi Holistik Sağlık Dergisi
    Year: 2023
    Date: 2023-12-30
    DOI: 10.54803/sauhsd.1381519
    Contributors: Ebubekir Kaplan, Aylin Aktaş Özakgül, Özkan Sir

  5. Title: Hemşirelerde Tiger Temelli Hemşirelik Bilişimi Yetkinlikleri ile Dijital Okuryazarlık Düzeyleri Arasındaki İlişkinin İncelenmesi: Makine Öğrenmesi Yaklaşımı ile Analizi
    Journal: Fenerbahçe Üniversitesi Sağlık Bilimleri Dergisi
    Year: 2023
    Date: 2023-12-29
    DOI: 10.56061/fbujohs.1252026
    Contributors: Metin Yıldız, Mehmet Yıldız, Mehmet Salih Yıldırım, Yakup Sarpdağı, Tuğçe Kabak, Ebubekir Kaplan, Mehmet Emin Atay

  6. Title: COVID-19 Pandemi Korkusu ile Hemşirelerin Bakım Verici Rolüne İlişkin Tutumları Arasındaki İlişki
    Journal: Sağlık Bilimleri Üniversitesi Hemşirelik Dergisi
    Year: 2021
    Date: 2021-12-15
    DOI: 10.48071/sbuhemsirelik.997960
    Contributors: Ebubekir Kaplan, Mehmet Cihad Aktaş, Hatice Kaya

Aylin Ozakgül | Health Professions | Best Researcher Award

Posted on by Shen Awards

Assoc. Prof. Dr. Aylin Ozakgül | Health Professions | Best Researcher Award

Associate Professor from İstanbul University-Cerrahpaşa, Department of Fundamentals of Nursing, Turkey

Assoc. Prof. Dr. Aylin Aktaş Özakgül is a distinguished academic in the field of nursing, currently serving at İstanbul University-Cerrahpaşa, Florence Nightingale Faculty of Nursing. Her expertise lies in the fundamentals of nursing, with a particular focus on individualized patient care, palliative care, and nursing education. Throughout her career, she has contributed significantly to nursing literature, emphasizing the importance of patient-centered approaches and the professional image of nursing. Her research endeavors have not only advanced academic understanding but have also had practical implications for nursing practices in Turkey. Dr. Özakgül’s commitment to nursing education and research has established her as a leading figure in her field.

Professional Profile

Education

Dr. Özakgül completed her undergraduate studies in nursing, followed by advanced degrees that deepened her expertise in the field. She earned her doctorate from İstanbul University-Cerrahpaşa, where she focused on the fundamentals of nursing. Her academic journey has been marked by a dedication to understanding and improving nursing practices, with a particular emphasis on individualized care and patient perceptions. Her educational background has provided a strong foundation for her subsequent research and teaching roles.

Professional Experience

Dr. Özakgül has held various academic positions, culminating in her current role as an Associate Professor at İstanbul University-Cerrahpaşa, Florence Nightingale Faculty of Nursing. In this capacity, she has been instrumental in shaping nursing curricula and mentoring the next generation of nurses. Her professional experience extends beyond teaching; she has actively participated in research projects that address critical issues in nursing, such as patient care quality and the professional image of nursing. Her contributions have had a lasting impact on both academic and clinical nursing practices in Turkey.

Research Interests

Dr. Özakgül’s research interests are centered around the fundamentals of nursing, with a particular focus on individualized patient care, palliative care, and the professional image of nursing. She has conducted studies analyzing graduate theses related to palliative care in Turkey, examining their methodologies and implications for nursing practices . Additionally, her research has explored factors affecting the perception of the nursing profession among Turkish high school students . Through her work, Dr. Özakgül aims to enhance the quality of nursing care and elevate the profession’s status within society.

Research Skills

Dr. Özakgül possesses a robust set of research skills, including qualitative and quantitative research methodologies, data analysis, and academic writing. Her ability to design and conduct comprehensive studies has led to valuable insights into nursing practices and education. She is adept at collaborating with interdisciplinary teams, which has enriched her research outcomes and broadened the impact of her work. Her proficiency in translating research findings into practical applications has been instrumental in advancing nursing practices in clinical settings.

Awards and Honors

Throughout her career, Dr. Özakgül has been recognized for her contributions to nursing education and research. Her publications have garnered attention in academic circles, and she has been invited to review articles for various nursing journals, reflecting her expertise and standing in the field . Her commitment to excellence in nursing has earned her accolades from academic institutions and professional organizations, underscoring her influence and leadership in the discipline.

Conclusion

Assoc. Prof. Dr. Aylin Aktaş Özakgül’s dedication to nursing education and research has significantly advanced the field in Turkey. Her focus on individualized patient care and the professional development of nurses has led to meaningful improvements in both academic and clinical settings. Through her scholarly work and mentorship, she continues to inspire and shape the future of nursing, ensuring that the profession evolves to meet the changing needs of society. Her contributions stand as a testament to the vital role of nursing in healthcare and the importance of continual learning and research in the field.

Publications Top Notes

  1. The effect of nursing care based on Comfort Theory of Kolcaba on comfort, satisfaction and sleep quality of intensive care patients
    Journal: Nursing in Critical Care
    Date: 2025-05
    DOI: 10.1111/nicc.70033
    Contributors: Ebubekir Kaplan, Aylin Özakgül

  2. Investigation of the relationship between spiritual care needs of relatives of patients hospitalized in intensive care unit and intensive care satisfaction in Turkey
    Journal: Nursing in Critical Care
    Date: 2024-07
    DOI: 10.1111/nicc.13024
    Contributors: Ebubekir Kaplan, Özkan Sir, Aylin Özakgül

  3. Yoğun Bakım Hastası İçin Erken Mobilizasyonun Önemi
    Journal: Sakarya Üniversitesi Holistik Sağlık Dergisi
    Date: 2023-12-30
    DOI: 10.54803/sauhsd.1381519
    Contributors: Ebubekir Kaplan, Aylin Aktaş Özakgül, Özkan Sir

  4. Care burden and related factors among informal caregivers of patients with amyotrophic lateral sclerosis
    Journal: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
    Date: 2023-01-02
    DOI: 10.1080/21678421.2022.2079993
    Contributors: Zeliha Tülek, Aylin Özakgül, Naile Alankaya, Aynur Dik, Alper Kaya, Pemra C. Ünalan, Ayşe Nilüfer Özaydin, Halil Atilla İdrisoğlu

  5. Non-Hodgkin Lenfoma ve COVID-19 Pnömonisi olan Hastanın Bireyselleştirilmiş Bakımı: Olgu Sunumu
    Journal: Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi
    Date: 2022-12-22
    DOI: 10.37989/gumussagbil.961384
    Contributors: Aylin Aktaş Özakgül, Esra Durmayüksel, Yasemin Gülizar Topçu, Hilmi Gözden

  6. Evaluation of the Perception of Illness and Quality of Life in Patients with Acute Myocardial Infarction
    Journal: Turk Kardiyoloji Dernegi Arsivi – Archives of the Turkish Society of Cardiology
    Date: 2022-04-14
    DOI: 10.5543/tkda.2022.21048
    Contributors: Aylin Özakgül

  7. Validity and reliability of the Turkish version of the amyotrophic lateral sclerosis assessment questionnaire
    Journal: Journal of Neuroscience Nursing
    Date: 2019
    DOI: 10.1097/JNN.0000000000000466
    EID: 2-s2.0-85071831328
    Contributors: Naile Alankaya, Zeliha Tülek, Aylin Özakgül, Alper Kaya, Aynur Dik

  8. Nursing Care of an Individual with Pituitary Tumor
    Journal: The Journal of Neurological and Neurosurgical Nursing
    Date: 2018-06
    DOI: 10.15225/pnn.2018.7.2.6
    Contributors: Aylin Özakgül

  9. The Effect of Training Provided to the Relatives of Stroke Patients on the Life Quality, Anxiety and Depressive Symptom Levels of Patients and Their Relatives
    Journal: The Journal of Neurological and Neurosurgical Nursing
    Date: 2018-06
    DOI: 10.15225/pnn.2018.7.2.1
    Contributors: Aylin Özakgül

  10. What are the Factors that Affect the Image of Nursing Profession of Turkish High School Students?
    Journal: International Archives of Nursing and Health Care
    Date: 2017-12-31
    DOI: 10.23937/2469-5823/1510085
    Contributors: Aylin Özakgül

Agete Tadewos Hirigo | Medicine and Dentistry | Excellence in Research Award

Posted on by Shen Awards

Mr. Agete Tadewos Hirigo | Medicine and Dentistry | Excellence in Research Award

Hawassa University, Ethiopia

Dr. Agete Tadewos Hirigo is an Assistant Professor at Hawassa University in Ethiopia, specializing in clinical chemistry and medical laboratory sciences. With a robust academic background and extensive research experience, he has significantly contributed to the fields of metabolic disorders, infectious diseases, and clinical diagnostics. Dr. Hirigo has authored over 40 peer-reviewed publications, reflecting his commitment to advancing medical science and improving healthcare outcomes in Ethiopia and beyond.

Professional Profile

Education

Dr. Hirigo’s academic journey began with a Diploma in Medical Laboratory Technology from Addis Ababa University in 2000. He then earned a BSc in Medical Laboratory Technology Sciences from Hawassa University in 2009. In 2012, he completed his MSc in Clinical Laboratory Sciences (Clinical Chemistry) at the University of Gondar. Currently, he is pursuing a PhD in Clinical Nutrition at Addis Ababa University, demonstrating his dedication to continuous learning and specialization in his field.

Professional Experience

Dr. Hirigo’s professional career spans over two decades. He started as a Senior Lab Technologist at Hawassa University Comprehensive Specialized Hospital from 2009 to 2011. He then served as an Expert Clinical Chemist from 2012 to 2015. From 2015 to 2019, he was a Lecturer at the School of Medical Laboratory Sciences, Hawassa University. Since July 2019, he has been serving as an Assistant Professor, where he is involved in lecturing, research, student supervision, and quality assurance in clinical chemistry laboratories.

Research Interests

Dr. Hirigo’s research interests are diverse and impactful. He focuses on metabolic disorders such as dyslipidemia and metabolic syndrome, particularly among HIV-infected and psychiatric patients. His work also encompasses the study of antiretroviral therapy effects, infectious diseases like hepatitis B and C, and public health issues such as hand hygiene practices among schoolchildren. His research aims to address critical health challenges in Ethiopia, contributing to evidence-based interventions and policies.

Research Skills

Dr. Hirigo possesses a comprehensive skill set in clinical laboratory sciences. His expertise includes laboratory diagnostics, clinical chemistry, and the use of statistical tools like SPSS for data analysis. He is proficient in designing and conducting cross-sectional and cohort studies, laboratory quality assurance, and instrument maintenance. His skills are instrumental in both academic research and practical laboratory settings, ensuring high standards of laboratory services and research outputs.

Awards and Honors

While specific awards and honors are not detailed in the available information, Dr. Hirigo’s extensive publication record and academic positions indicate recognition in his field. His involvement in significant research projects and collaborations with other institutions reflect his esteemed status in the academic and medical communities.

Conclusion

Dr. Agete Tadewos Hirigo exemplifies the qualities of a dedicated researcher and educator. His extensive experience, diverse research interests, and commitment to improving healthcare through science make him a valuable asset to the medical community. His work not only advances scientific knowledge but also has practical implications for public health in Ethiopia. Dr. Hirigo’s ongoing contributions continue to inspire and influence the field of clinical laboratory sciences.

Publications Top Notes

📘 1. Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation
Authors: SJ Connolly, G Karthikeyan, M Ntsekhe, A Haileamlak, A El Sayed, …
Journal: New England Journal of Medicine, 387(11), 978–988 (2022)
Citations: 200
🔬 Major randomized trial comparing rivaroxaban and vitamin K antagonists in RHD-AF.

📘 2. Hyperuricemia and Metabolic Syndrome in Type 2 Diabetes Mellitus Patients at Hawassa University
Authors: SB Woyesa, AT Hirigo, TB Wube
Journal: BMC Endocrine Disorders (2017)
Citations: 96
🧪 Correlation study of uric acid levels and metabolic syndrome in diabetic patients.

📘 3. Prevalence of Dyslipidemia Among HIV-Infected Patients Using First-Line HAART
Authors: A Tadewos, Z Addis, H Ambachew, S Banerjee
Journal: AIDS Research and Therapy (2012)
Citations: 91
🩺 Comparative cross-sectional analysis in Southern Ethiopia.

📘 4. Burden of Metabolic Syndrome Among HIV-Infected Patients in Southern Ethiopia
Authors: DY Tesfaye, S Kinde, G Medhin, YC Megerssa, A Tadewos, E Tadesse, …
Journal: Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 8(2), 102–107 (2014)
Citations: 84
🧬 Assessment of metabolic complications among PLHIV on ART.

📘 5. Hepatitis B Virus Among Pregnant Women in Yirgalem Hospital, Ethiopia
Authors: A Amsalu, G Ferede, S Eshetie, A Tadewos, D Assegu
Journal: Journal of Pregnancy (2018), Article ID: 8435910
Citations: 78
👶 Implication of HBV screening for preventing mother-to-child transmission.

📘 6. The INVICTUS Rheumatic Heart Disease Research Program
Authors: G Karthikeyan, SJ Connolly, M Ntsekhe, A Benz, S Rangarajan, G Lewis, …
Journal: American Heart Journal, 225, 69–77 (2020)
Citations: 52
🫀 Study design for comparing rivaroxaban vs. VKA in RHD.

📘 7. Gender Influence in Metabolic Syndrome Among PLHIV on ART
Authors: AT Hirigo, DY Tesfaye
Journal: BMC Research Notes (2016)
Citations: 45
📊 Exploration of sex-based differences in ART-related metabolic issues.

📘 8. Length of Stay in Emergency Departments in Southern Ethiopia
Authors: GH Alemu, KG Negari, KM Rodamo, AT Hirigo
Journal: BMC Research Notes (2019)
Citations: 43
🏥 Study of variables influencing emergency department stay duration.

📘 9. Hand Washing Practices Among Primary Schoolchildren in Yirgalem
Authors: D Eshetu, T Kifle, AT Hirigo
Journal: Journal of Multidisciplinary Healthcare (2020), 759–768
Citations: 36
🧼 KAP study on hygiene practices among schoolchildren.

📘 10. Coinfections with Hepatitis B, C, and Syphilis Among HIV Patients
Authors: T Shimelis, Y Tassachew, A Tadewos, MW Hordofa, A Amsalu, …
Journal: HIV/AIDS – Research and Palliative Care
Citations: 33
⚕️ Cross-sectional data on coinfection rates in PLHIV.

 

Mohamed Nasreldin | Medicine and Dentistry | Excellence in Research Award

Posted on by Shen Awards

Assist. Prof. Dr. Mohamed Nasreldin | Medicine and Dentistry | Excellence in Research Award

Consultant Nephrologist from Imam Abdulrahman Bin Faisal, Saudi Arabia

Dr. Mohamed Ahmed Nasreldin is an American consultant internist and nephrologist currently serving as Assistant Professor at King Fahad Hospital of the University (KFHU), Dammam, Saudi Arabia. With over 16 years of clinical experience, he has demonstrated exceptional competence in both internal medicine and nephrology, managing complex cases with compassion, precision, and interdisciplinary collaboration. Dr. Nasreldin holds a rich academic background complemented by international qualifications and fellowships, including the prestigious Fellow of the American Society of Nephrology (FASN). His work spans clinical care, teaching, and research, particularly in dialysis, kidney transplantation, and interventional nephrology. A committed educator, he has contributed significantly to medical education by tutoring nephrology fellows and mentoring residents and medical students. His fluency in Arabic, English, and Russian enhances his ability to connect across cultures and deliver impactful education and care. Dr. Nasreldin has received several awards and certificates of appreciation for his excellence in research presentations, academic contributions, and leadership in clinical practice. With a strong foundation in research and clinical trials, he has authored multiple peer-reviewed publications and continues to contribute to national and international nephrology forums. His career reflects a balanced dedication to patient care, clinical innovation, and academic leadership.

Professional Profile

Education

Dr. Mohamed Ahmed Nasreldin has pursued a comprehensive and international academic journey in medicine and nephrology. He holds a PhD in Clinical Nephrology (2016–2019) from UCN, USA, and a Clinical MD in Internal Medicine from Odessa State Medical University, Ukraine (2005–2009). He also earned an MBBS with honors in Medicine and Surgery from the same institution. His postgraduate education includes an MSc in Renal Medicine and a Postgraduate Diploma in Renal Medicine from the University of South Wales, UK. Dr. Nasreldin’s credentials also include the European Specialty Examination in Nephrology (ESENeph), jointly administered by the UEMS and the Royal College of Physicians, UK, along with a Fellowship from the American Society of Nephrology (FASN) awarded in 2019. His education is further supported by numerous certifications from globally recognized institutions, such as Johns Hopkins University (clinical research), the University of Leiden (kidney and pancreas transplantation), and the Royal College of Physicians, UK (renal medicine). In addition, he has completed specialized training in kidney pathology, gout management, and ADPKD treatment. This robust academic foundation not only underpins his clinical and research proficiency but also reflects his commitment to lifelong learning and evidence-based practice.

Professional Experience

With 16 years of experience in internal medicine and nephrology, Dr. Mohamed Nasreldin has established himself as a highly competent and dedicated clinician. He began his medical career with a residency program at Odessa State Medical University, where he gained extensive exposure to various subspecialties. Since 2009, he has been an integral part of the internal medicine department at King Fahad Hospital of the University (KFHU), Saudi Arabia. In this role, he manages both inpatient and outpatient care, including hemodialysis and peritoneal dialysis patients, and is actively involved in hospital consultations and on-call duties. Dr. Nasreldin’s clinical expertise covers a broad spectrum, from acute kidney injury and chronic kidney disease to renal transplantation and interventional nephrology. In addition to his clinical responsibilities, he plays a pivotal role in medical education and training. He tutors nephrology fellows, mentors residents, and delivers lectures to undergraduate and postgraduate students. His leadership in clinical care, education, and patient safety has been consistently recognized by peers and institutional authorities. Known for his problem-solving abilities under pressure, team collaboration, and organizational skills, Dr. Nasreldin continues to contribute significantly to both patient outcomes and the development of future nephrologists.

Research Interests

Dr. Mohamed Nasreldin’s research interests lie primarily in clinical nephrology, with a strong focus on dialysis modalities, renal transplantation, and interventional nephrology. He is particularly passionate about improving outcomes for patients on peritoneal dialysis and exploring patient-centered decision-making processes in renal care. His doctoral research examined the use of prophylactic antibiotics in end-stage renal disease (ESRD) patients undergoing colonoscopy while on automated peritoneal dialysis—a prospective randomized controlled trial that reflects his commitment to optimizing clinical protocols through evidence-based research. Dr. Nasreldin is also interested in transplant nephrology, including the management of acute and chronic allograft nephropathy, and the development of new catheter insertion techniques. His research extends to diabetes-related kidney disease, endothelial dysfunction in ischemic heart disease, and innovative strategies in nephrology education and practice. He has actively participated in clinical trials, presented findings at national and international conferences, and published research aimed at improving therapeutic outcomes in nephrology. As a mentor, he supervises clinical research for residents and fellows, fostering an academic environment that values inquiry and innovation. His dedication to research enhances his clinical practice, ensuring that patients benefit from the most current and effective medical interventions.

Research Skills

Dr. Nasreldin possesses a well-rounded set of research skills developed over more than a decade of conducting clinical investigations in internal medicine and nephrology. He is experienced in the design, monitoring, and execution of clinical trials, particularly randomized controlled studies that assess new interventions in renal care. His skills encompass the formulation of research hypotheses, patient recruitment and consent, data collection and analysis, and the interpretation of clinical findings for publication and presentation. Dr. Nasreldin is also proficient in guiding research as a supervisor and mentor, especially for nephrology fellows and internal medicine residents. His methodological strengths include statistical analysis, critical appraisal of the literature, and integration of research into clinical practice. Additionally, his ability to present research findings at scientific forums and publish in peer-reviewed journals underscores his communication and academic writing abilities. He is trained in research ethics and regulatory compliance, having completed a clinical research certificate from Johns Hopkins University. His involvement in various educational workshops and clinical symposiums enhances his collaborative research experience. These research skills have enabled him to contribute significantly to medical knowledge in nephrology, while also improving clinical decision-making and patient outcomes.

Awards and Honors

Dr. Mohamed Nasreldin has been recognized multiple times for his contributions to nephrology through awards and certificates of appreciation, reflecting both his clinical excellence and academic achievements. Notably, he received a Certificate of Appreciation at the First Gulf Peritoneal Dialysis Forum in Oman (2024) and won first place for poster presentation at the ISN-EMAN Update Congress in Nephrology, Dubai (2017). His oral presentation on acute kidney injury at the Saudi International Congress of Nephrology and Transplantation (2018) earned commendation, as did his role as a speaker at the International Conference of Diabetes and Its Complications in Baltimore (2017). He was honored by the nephrology division at King Fahad Hospital of the University for upholding high standards of care aligned with JCI requirements. Additionally, his participation in public awareness events, such as World Kidney Day, and academic initiatives like the 3rd Annual Research Day at King Saud University (2012), further illustrate his professional commitment. These accolades emphasize his role as a thought leader in nephrology, combining research, clinical practice, and public engagement. The consistent recognition from national and international platforms affirms Dr. Nasreldin’s impact on advancing kidney health and medical education.

Conclusion

Dr. Mohamed Ahmed Nasreldin stands out as a distinguished clinician, educator, and researcher in the field of nephrology, making him a strong candidate for the Excellence in Research Award. His extensive academic background, including a PhD in clinical nephrology and fellowship with the American Society of Nephrology, lays the foundation for his clinical acumen and research productivity. With over 16 years of experience, Dr. Nasreldin has shown exemplary commitment to improving patient outcomes, mentoring the next generation of physicians, and contributing to the scientific community. His research spans dialysis innovations, kidney transplantation, and interventional nephrology, all grounded in real-world clinical challenges. While his scholarly output could benefit from more high-impact journal publications and international collaborations, his existing contributions and active engagement in medical forums are noteworthy. Dr. Nasreldin’s work aligns closely with the criteria for the Excellence in Research Award—particularly through his original investigations, teaching impact, and patient-centered clinical innovations. His trajectory reflects a blend of practical application and academic inquiry, reinforcing his value to the nephrology community. Continued institutional support and broader research dissemination could further enhance his profile, making him not only a deserving recipient but also a future leader in academic nephrology.

Publications Top Notes

  1. An update on sickle cell nephropathy
    Author: A. Alhwiesh
    Journal: Saudi Journal of Kidney Diseases and Transplantation, 25(2), 249–265
    Year: 2014
    Citations: 54

  2. The use of SGLT2 inhibitors in peritoneal dialysis patients: a shade of light on dapagliflozin
    Authors: A.K. Alhwiesh, I.S. Abdul-Rahman, M.A. Nasreldin, A.M. Mohammed, …
    Journal: Archives of Nephrology and Urology, 5(1), 1–8
    Year: 2022
    Citations: 15

  3. Pregnancy in peritoneal dialysis and an infant with a ventricular septal defect
    Author: A. Alhwiesh
    Journal: Saudi Journal of Kidney Diseases and Transplantation, 26(1), 111–114
    Year: 2015
    Citations: 8

  4. A nephrologist dream of peritoneal dialysis catheter with zero migration: a multicenter prospective study
    Authors: A.K. Al‐Hwiesh, I.S. Abdul‐Rahman, J.C. Divino‐Filho, M.A. Nasreldin, …
    Journal: Therapeutic Apheresis and Dialysis, 28(1), 89–95
    Year: 2024
    Citations: 5

  5. A novel three cuff peritoneal dialysis catheter with low entry technique: three years single center experience
    Authors: A. Al-Hwiesh, I. Abdul-Rahman, N. Al-Audah, A. Noor, M. Nasreldin
    Journal: Urol Nephrol Open Access J, 4(5), 150–156
    Year: 2017
    Citations: 5

  6. The problem of pulmonary arterial hypertension in end-stage renal disease: can peritoneal dialysis be the solution
    Authors: A.K. Alhwiesh, I.S. Abdul-Rahman, A. Alshehri, A. Alhwiesh, M. Elnokeety, …
    Journal: BMC Nephrology, 23(1), 386
    Year: 2022
    Citations: 4

  7. Is percutaneous gastrostomy tube insertion contraindicated in adult peritoneal dialysis patients? A single-centre experience of three successful cases: it is time to revisit
    Authors: A. Alhwiesh, L. Alayoobi, H.A. Aljenaidi, K.M. Alshehabi, I. Abokaker Alghnimi, …
    Journal: The International Journal of Artificial Organs, 45(4), 438–441
    Year: 2022
    Citations: 2

  8. THE SAUDI PERITONEAL DIALYSIS CATHETER: MODIFIED CATHETER AND NEW TECHNIQUE: FAREWELL TO CATHETER MIGRATION
    Authors: A. Alhwiesh, M. Nasreldin
    Journal: Nephrology Dialysis Transplantation, 31
    Year: 2016
    Citations: 2

  9. The influence of increased peritoneal membrane surface area on dialysis adequacy
    Authors: A. Alhwiesh, S. Esam, I. Saeed, M. Ahmmed, F. Almohana
    Journal: Saudi Journal of Kidney Diseases and Transplantation, 22(4), 717–722
    Year: 2011
    Citations: 2

Xia Chen | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Ms. Xia Chen | Medicine and Dentistry |  Best Researcher Award

Professor from Yunnan Provincial Hospital of Chinese Medicine, China

Xia Chen is an accomplished chief physician, professor, and master’s supervisor, specializing in integrated Chinese and Western medicine, particularly in gastroenterology. Born in 1978 in Yunnan, China, she has devoted more than two decades to clinical practice, teaching, and scientific research. Currently, she serves as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at Yunnan Provincial Hospital of Chinese Medicine. She has gained recognition as an Outstanding Young Practitioner of Chinese Medicine in Yunnan Province and holds membership in the Hepatobiliary Disease Branch of the Chinese Medical Association. Her career focuses on the diagnosis and treatment of digestive diseases using both traditional Chinese medicine and Western medicine approaches. Xia Chen’s contribution extends beyond clinical work to research projects, drug trials, and academic publishing. Her ability to bridge traditional and modern medical practices has made her a notable figure in her field. Over the years, she has led and participated in numerous prestigious research projects and has authored or co-authored several scholarly works. Xia Chen’s career reflects dedication to improving healthcare outcomes through integrated medicine and advancing research in digestive health, making her a leader in her specialty and an inspiration for future researchers and clinicians.

Professional Profile

Education

Although detailed information about Xia Chen’s educational background is not explicitly provided, her current standing as a chief physician and professor suggests a comprehensive academic journey in medicine, likely beginning with a bachelor’s degree in traditional Chinese medicine or clinical medicine. Following her undergraduate studies, it is plausible she pursued further specialization, completing advanced degrees, possibly a master’s degree or doctorate, focusing on integrated Chinese and Western medicine with a specialty in digestive diseases. Xia Chen’s position as a master’s supervisor also indicates her formal academic qualification aligns with national standards for academic leadership roles in China, which typically require at least a master’s degree combined with significant clinical expertise. Her education would have provided her a strong foundation in traditional Chinese medical principles, combined with extensive training in modern clinical practices, pharmacology, and research methodology. Given her leadership in research projects and teaching, she likely continued her professional development through certifications, clinical fellowships, and continuous medical education programs. Her educational journey underpins her expertise in gastroenterology and serves as the backbone for her clinical, academic, and research excellence.

Professional Experience

Xia Chen has built a remarkable professional career, accumulating over 20 years of experience in clinical practice, teaching, and research in the field of integrated Chinese and Western medicine. She currently serves as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at Yunnan Provincial Hospital of Chinese Medicine. Her daily responsibilities include diagnosing and treating patients with complex digestive diseases, mentoring master’s students, and overseeing research activities. She has established herself as a specialist who skillfully combines traditional Chinese medical therapies with modern Western treatments, offering holistic and effective patient care. Xia Chen’s leadership extends to supervising clinical trials and participating in national Phase II, III, and IV drug research studies. Her practical skills are complemented by her academic contributions, which include teaching future healthcare professionals and guiding research initiatives. Furthermore, she actively contributes to healthcare policy improvements through her roles in professional associations such as the Hepatobiliary Disease Branch of the Chinese Medical Association. Her professional experience highlights her comprehensive expertise across clinical, academic, and scientific domains, making her a pivotal figure in advancing the integration of traditional Chinese medicine with contemporary medical science.

Research Interests

Xia Chen’s research interests focus on the integration of traditional Chinese medicine and Western medicine approaches to digestive diseases. A significant part of her work explores the therapeutic effects of natural medicines on intestinal dynamics. Her research aims to scientifically validate the efficacy of traditional remedies and their mechanisms of action, thereby bridging the gap between ancient practices and modern clinical science. Additionally, Xia Chen is deeply interested in clinical trials related to new drug developments, having participated in numerous national Phase II, III, and IV studies. Her research spans studying gastrointestinal motility disorders, chronic digestive conditions, and hepatobiliary diseases. She is particularly motivated by the desire to develop more effective, less invasive, and side-effect-minimized treatments through integrative approaches. Another important research area for Xia Chen is understanding how traditional Chinese formulations can complement or enhance the effects of Western pharmacological interventions. Her research is highly practical, patient-centered, and innovative, targeting improvements in clinical outcomes. With a growing emphasis on evidence-based medicine, her work contributes significantly to validating and modernizing traditional Chinese medicinal practices while maintaining their historical integrity and therapeutic richness.

Research Skills

Xia Chen possesses a broad range of research skills that have been instrumental in her professional success. She demonstrates expertise in designing and conducting clinical trials, especially those combining traditional Chinese medicinal approaches with Western methodologies. Her skill set includes protocol development, patient recruitment and management, data analysis, and reporting in accordance with national and international standards. She is proficient in evaluating the pharmacological effects of natural medicines and their applications in digestive health. Xia Chen’s publication record highlights her ability to carry out longitudinal studies and synthesize findings for publication in peer-reviewed journals. Her role as a master’s supervisor also reflects her ability to guide young researchers in research design, methodology, and thesis writing. Furthermore, her participation in over ten national drug studies indicates advanced skills in regulatory compliance, clinical pharmacology, and interdisciplinary collaboration. Xia Chen’s integrated approach to traditional and modern research paradigms exemplifies her unique strengths. Her research methodology is thorough, combining qualitative insights from traditional Chinese medicine with the quantitative rigor required in modern clinical research. These combined skills make her a formidable researcher capable of making impactful contributions to the field.

Awards and Honors

Throughout her distinguished career, Xia Chen has received notable awards and honors recognizing her professional and academic contributions. She has been named an Outstanding Young Practitioner of Chinese Medicine in Yunnan Province, an accolade that underscores her clinical excellence, research innovation, and contributions to the advancement of traditional Chinese medicine. Her appointment as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at the Yunnan Provincial Hospital of Chinese Medicine is itself a recognition of her expertise and leadership capabilities. Furthermore, her active membership in the Hepatobiliary Disease Branch of the Chinese Medical Association reflects national recognition of her skills and knowledge. These honors highlight her respected position within the Chinese medical community. They also affirm her commitment to bridging traditional Chinese medicine with modern clinical practices. While specific awards for research publications or international recognition have not been detailed, her extensive leadership in research projects and contribution to multiple monographs reinforce her academic and professional stature. Xia Chen’s awards and honors validate her significant and ongoing impact in the field of integrated medicine and gastroenterology.

Conclusion

Xia Chen is a highly accomplished clinician, educator, and researcher whose career embodies excellence in integrating traditional Chinese and Western medical practices. Her dedication to advancing digestive health through innovative, interdisciplinary methods sets her apart as a leader in her field. With over two decades of professional experience, leadership in major research projects, and numerous scholarly contributions, she has significantly impacted both clinical practice and academic research. Her recognition as an Outstanding Young Practitioner of Chinese Medicine and leadership roles within national medical organizations reflect her esteemed reputation. While opportunities exist for expanding her international research presence, Xia Chen’s current achievements already demonstrate her remarkable expertise, commitment, and influence. She serves as a bridge between ancient medical wisdom and contemporary science, promoting holistic and evidence-based healthcare solutions. As she continues to build on her impressive body of work, Xia Chen is poised to make even greater contributions to global medical science, ensuring that traditional Chinese medicine remains relevant, respected, and scientifically validated in the modern era.

Publications Top Notes

  • Title: Quercetin Inhibits Cardiomyocyte Apoptosis via Sirt3/SOD2/Mitochondrial Reactive Oxygen Species During Myocardial Ischemia–Reperfusion Injury

  • Authors: Xiong Da, Wang Xin, Wang Haiyu, Zhao Zicong, Ren Wenjun

  • Year: 2024

  • Citations: 6

Ren Guibing | Medicine and Dentistry | Best Researcher Award

Posted on by Shen Awards

Assoc. Prof. Dr. Ren Guibing | Medicine and Dentistry | Best Researcher Award

Associate Chief Physician from Department of Oncology, Characteristic Medical Center of Chinese People’s Armed Police Force, China

Assoc. Prof. Dr. Ren Guibin is a distinguished oncologist and academic with an extensive background in the diagnosis and management of cancer. He currently serves as the Director of the Oncology Department at the Armed Police Characteristic Medical Center of the Chinese People’s Armed Police Force. With over 30 peer-reviewed publications, Dr. Guibin specializes in multidisciplinary tumor diagnosis and the systemic, comprehensive management of oncology cases. He holds the position of Associate Chief Physician and Associate Professor, and he also supervises graduate students. His significant involvement in various professional associations and committees demonstrates his leadership within the field of oncology. Dr. Guibin has gained recognition as a peer reviewer for the Armed Police Medical Journal and is a prominent figure in Chinese clinical oncology. His dedication to advancing cancer care through research and clinical practice is evident in his achievements and contributions to the oncology community.

Professional Profile

Education

Dr. Ren Guibin earned his medical degree (M.D.) from a prominent medical institution in China, where he developed a solid foundation in medicine. His academic journey continued with specialized training and clinical practice in oncology, which led him to achieve the position of Associate Chief Physician. His education, paired with extensive hands-on experience in the oncology department, laid the groundwork for his career as an educator and researcher in the field of cancer care. Throughout his career, Dr. Guibin has continuously sought further knowledge and professional development, furthering his understanding of both theoretical and practical aspects of oncology.

Professional Experience

Assoc. Prof. Dr. Ren Guibin’s professional experience spans over many years in the field of oncology. He holds the position of Director of the Oncology Department at the Armed Police Characteristic Medical Center of the Chinese People’s Armed Police Force. Dr. Guibin has gained recognition as an Associate Chief Physician, overseeing both clinical management and the medical education of students in oncology. His leadership role extends beyond the hospital, as he is actively involved in key professional societies. As a Master’s supervisor, Dr. Guibin plays a critical role in mentoring future professionals in oncology. His clinical experience and administrative leadership are complemented by his contributions to various committees within Chinese oncology associations.

Research Interests

Dr. Ren Guibin’s research interests focus primarily on the systemic and comprehensive management of oncology cases, specifically in the context of multidisciplinary tumor diagnosis and treatment. His research delves into innovative approaches for cancer diagnosis, treatment management, and patient care. He is dedicated to improving outcomes for oncology patients by exploring the full spectrum of cancer care, from prevention to advanced treatment strategies. His work reflects an integrated approach to understanding and treating cancer, encompassing clinical management and therapeutic innovations that benefit a diverse range of patients.

Research Skills

Assoc. Prof. Dr. Ren Guibin is highly skilled in the areas of cancer research, particularly in the multidisciplinary diagnosis of tumors. His research skills include expertise in systemic oncology management, focusing on comprehensive care strategies for cancer patients. Dr. Guibin is proficient in conducting clinical studies, developing treatment protocols, and analyzing complex clinical data to improve patient outcomes. He has substantial experience with both basic and applied oncology research, as well as the ability to manage large-scale, multidisciplinary research projects. Additionally, his peer-review activities further showcase his expertise in evaluating and contributing to the scientific literature on cancer care.

Awards and Honors

Throughout his distinguished career, Assoc. Prof. Dr. Ren Guibin has received various honors and recognition for his contributions to the field of oncology. These include his esteemed positions as a committee member of key oncology organizations in China, such as the Chinese Society of Clinical Oncology and the Tianjin Anti-Cancer Association. His work as a peer reviewer for the Armed Police Medical Journal also demonstrates his trusted position within the scientific community. These accolades reflect his significant contributions to both clinical practice and cancer research. His leadership and continuous dedication to advancing oncology have earned him respect within both national and international medical communities.

Conclusion

Assoc. Prof. Dr. Ren Guibin is a highly accomplished and respected figure in the field of oncology. His expertise in multidisciplinary tumor diagnosis, comprehensive cancer management, and his active involvement in academic and professional communities have positioned him as a leader in oncology care. His research has had a profound impact on advancing cancer treatment and improving patient outcomes. Dr. Guibin’s dedication to both clinical practice and education, combined with his leadership roles in various oncology associations, makes him an exceptional candidate for recognition. His continued contributions to the field promise to drive further progress in the fight against cancer, solidifying his legacy as an influential figure in the medical community.

Publication Top Note

  1. The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia
    Authors: Wenqi Wu, Yanan Jiang, Donghui Xing, Guibing Ren, Zhigang Zhao
    Year: 2024
    Citations: 3